Monday, April 6, 2026
ADVT 
National

AstraZeneca double-dosers react to NACI advice

Darpan News Desk The Canadian Press, 18 Jun, 2021 10:44 AM
  • AstraZeneca double-dosers react to NACI advice

When Gwenny Farrell booked her second dose of the Oxford-AstraZeneca COVID-19 vaccine on the first day it became available, she said she believed she was doing the right thing.

The resident of White Rock, B.C., said she has tried to follow every health protocol and recommendation strictly, so her confidence has been shaken by a new recommendation from the National Advisory Committee on Immunization on mixing the vaccines.

On June 1, NACI had said AstraZeneca recipients "could" get Pfizer-BioNTech or Moderna for their second shot if they wanted, but on Thursday it went further to say an mRNA vaccine was the "preferred" choice.

"I'm frustrated because now, after being told for months that the best vaccine is the first one that's in your arm, I'm being told I may have made a mistake," Farrell, 55, said.

The new recommendation is drawing mixed reaction from those who've already received two jabs of AstraZeneca. Farrell is not alone in her disappointment, while others say they remain happy with their choice because they know it still means they are well protected against COVID-19.

The committee's guidance is based on the growing supply of mRNA vaccines, growing evidence that a second dose of an mRNA vaccine produces a stronger immune response, and because of the low but serious risk of vaccine-induced blood clots associated with AstraZeneca.

"People who received two doses of AstraZeneca/COVISHIELD vaccine can rest assured that the vaccine provides good protection against infection and very good protection against severe disease and hospitalization,'' NACI's advice says.

The committee also updated its previous recommendation that people at high risk of exposure to, or serious illness from, COVID-19, could opt to get AstraZeneca rather than waiting for Pfizer or Moderna. Now NACI says everyone should always get the mRNA vaccines first, unless they are allergic to them.

However, officials in Quebec and British Columbia didn't move to follow NACI's advice, instead saying residents can still make a personal choice for either a mixed schedule or two doses of AstraZeneca.

"The very real world evidence shows us we have good protection across the board with both vaccines in our community," B.C. provincial health officer Dr. Bonnie Henry said.

As of June 5, 2.1 million Canadians had received one dose of AstraZeneca, and 15,186 had received two doses.

There are no further shipments of AstraZeneca scheduled, but there are still about half a million doses of it in the provinces.

Toronto resident Sophie Nadeau said she remains grateful that she got her second AstraZeneca jab on Tuesday.

"I mean I'm fully vaccinated, that's amazing," she said.

Nadeau said she made the best decision she could with the information available at the time. As a single mother who hasn't been able to see her parents in a long time, it was important to get the first vaccine that was available.

As a public relations professional, Nadeau said she has a lot of empathy for those responsible for communicating what she understands to be naturally evolving recommendations as new evidence becomes available.

"There are no perfect choices when it comes to COVID-19," she said, adding the pandemic has made everyone develop risk assessment skills.

"I really do feel like for the last year and a half, every single thing has become an assessment of risk: from masks, to letting my kids out, to seeing my parents or choosing not to in this case. By this point, I've kind of become emotionally prepared for the story to change."

Mike Farnworth, British Columbia's minister of public safety, said he got his second AstraZeneca dose last week and would do the same if it was available this week.

He said his message to other British Columbians who have received two doses is the same: "Don't worry, you're fully vaccinated."

Others aren't so sure. Michael Slavitch, 54, made two separate appointments for his second dose because of mixed advice.

He now plans to cancel his AstraZeneca appointment Monday and keep his appointment for an mRNA shot.

Slavitch said he's particularly concerned about whether his AstraZeneca vaccine, or mixing and matching, will be accepted by other countries as international travel opens up.

"I'm confused about what to do," he said. "Our government is responsible for cleaning up this mess."

 

MORE National ARTICLES

Israeli-Palestinian tensions persist within NDP

Israeli-Palestinian tensions persist within NDP
The party has released its list of resolutions up for debate at the event, including a half-dozen that articulate solidarity with Palestinian causes or call for sanctions and stronger condemnation of Israel.

Israeli-Palestinian tensions persist within NDP

PHAC ordered to explain fired scientists

PHAC ordered to explain fired scientists
PHAC president Iain Stewart has refused to explain to the committee why Xiangguo Qiu and her husband, Keding Cheng, were fired in January, 18 months after being escorted from the National Microbiology Laboratory in Winnipeg.

PHAC ordered to explain fired scientists

Lower Mainland vaccine response 'overwhelming'

Lower Mainland vaccine response 'overwhelming'
A statement issued by the Ministry of Health said appointments opened today, but London Drugs posted a message Tuesday saying all bookings at its three designated sites had been filled.

Lower Mainland vaccine response 'overwhelming'

COVID-19 side-effect: flu cases way down in Canada

COVID-19 side-effect: flu cases way down in Canada
There has been no evidence of flu spreading in the community, no confirmed outbreaks and the number of hospitalizations and deaths due to the flu is zero.

COVID-19 side-effect: flu cases way down in Canada

Pandemic to plunge deficit to $363B, PBO says

Pandemic to plunge deficit to $363B, PBO says
The economy too is faring better than Giroux anticipated, and his office has revised its projections for economic growth starting in the second half of this year.

Pandemic to plunge deficit to $363B, PBO says

Toronto to get new vaccine-manufacturing plant

Toronto to get new vaccine-manufacturing plant
The project will create 1,225 jobs and Sanofi will also invest at least $79 million a year to fund Canadian research and development.

Toronto to get new vaccine-manufacturing plant